A. R. Azevedo, V. F. Ferreira, H. de Mello, L. R. LeaoFerreira, A. V. Jabor, I. C. P. P. Frugulhetti, H. S. Pereira, N. Moussatche and A. M. R. Bernardino, “Synthesis And Biological Evaluation of 1h-Pyrazolo[3,4-b]pyridine-5 Carboxylic Acids against Vaccinia Virus,” Heterocyclic Communications, Vol. 8, No. 5, 2002, pp. 427-423. http://dx.doi.org/10.1515/HC.2002.8.5.427

has been cited by the following article:

• TITLE: Docking Studies, Synthesis, and Evaluation of Antioxidant Activities of N-Alkylated, 1,2,4-Triazole, 1,3,4-Oxa-, and Thiadiazole Containing the Aminopyrazolopyridine Derivatives

  AUTHORS: Yasser K. Abdelmonem, Farag A. El-Essawy, Saeda A. Abou El-Enein, Mona M. El-Sheikh-Amer

  KEYWORDS: Pyrazolopyridine; Biologically Active; Molecular Modeling and Inhibitor

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.3 No.3, September 24, 2013

  ABSTRACT: Synthesis of some 1,3,4-thia-, oxa-diazol and 1,2,4 triazole incorporated the biologically active and the pyrazolopyri-dine derivative. Molecular modeling and docking of the active compounds into AKR1C3 complexed with its bound inhibitor indomethacin using Molsoft ICM 3.4-8C program were performed in order to predict the affinity and orientation of the synthesized compounds at the active site.